{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T18:02:46Z","timestamp":1760983366142},"reference-count":8,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Med. Toxicol."],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1007\/bf03178278","type":"journal-article","created":{"date-parts":[[2009,12,9]],"date-time":"2009-12-09T09:45:15Z","timestamp":1260351915000},"page":"259-259","source":"Crossref","is-referenced-by-count":2,"title":["In response to Morris et al.\u2019s \u201cNeuroleptic malignant syndrome developing after acute overdose with olanzapine and chlorpromazine\u201d"],"prefix":"10.1007","volume":"5","author":[{"given":"Ken","family":"Gillman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"issue":"1","key":"BF03178278_CR1","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/BF03160978","volume":"5","author":"E Morris","year":"2009","unstructured":"Morris E, Green D, Graudins A. Neuroleptic malignand syndrome developing after acute overdose with olanzapine and chlorpromazine.J Med Toxicol. 2009;5(1):24\u201326.","journal-title":"J Med Toxicol."},{"issue":"1","key":"BF03178278_CR2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/10401230601163477","volume":"19","author":"JW Lee","year":"2007","unstructured":"Lee JW. Catatonic variants, hyperthermic extrapyramidal reactions, andsubtypes of neuroleptic malignant syndrome.Ann Clin Psychiatry. 2007;19(1):9\u201316.","journal-title":"Ann Clin Psychiatry"},{"issue":"12","key":"BF03178278_CR3","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1002\/mds.20689","volume":"20","author":"A Thomas","year":"2005","unstructured":"Thomas A, Onofrj M. Akinetic crisis, acute akinesia, neuroleptic malignant-like syndrome, Parkinsonism-hyperpyrexia syndrome, and malignant syndrome are the same entity and are often independent of treatment withdrawal.Mov Disord. 2005;20(12):1671.","journal-title":"Mov Disord"},{"issue":"1\u20133","key":"BF03178278_CR4","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ejphar.2008.07.040","volume":"594","author":"D Cussac","year":"2008","unstructured":"Cussac D, Boutet-Robinet E, Ailhaud MC, et al. Agonistdirected trafficking of signalling at serotonin 5-HT2A, 5-HT2B and 5-HT2C-VSV receptors mediated Gq\/11 activation and calcium mobilisation in CHO cells.Eur J Pharmacol. 2008;594(1\u20133): 32\u201338.","journal-title":"Eur J Pharmacol."},{"issue":"4","key":"BF03178278_CR5","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1097\/01.shk.0000175894.18168.66","volume":"24","author":"CP Chang","year":"2005","unstructured":"Chang CP, Chen SH, Lin MT. Ipsapirone and ketanserin protects against circulatory shock, intraranial hypertension, and cerebral ischemia during heatstroke.Shock. 2005;24(4):336\u2013340.","journal-title":"Shock"},{"issue":"2","key":"BF03178278_CR6","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1124\/jpet.102.039883","volume":"303","author":"A Newman-Tancredi","year":"2002","unstructured":"Newman-Tancredi A, Cussac D, Quentric Y, et al. Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. III. Agonist and antagonist properties at serotonin, 5-HT(1) and 5-HT(2), receptor subtypes.J Pharmacol Exp Ther. 2002;303(2):815\u2013822.","journal-title":"J Pharmacol Exp Ther."},{"key":"BF03178278_CR7","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1113\/jphysiol.1978.sp012476","volume":"282","author":"B Cox","year":"1978","unstructured":"Cox B, Kerwin R, Lee TF. Dopamine receptors in the central thermoregulatory pathways of the rat.J Physiol. 1978;282:471\u2013483.","journal-title":"J Physiol."},{"issue":"7","key":"BF03178278_CR8","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1212\/01.WNL.0000157058.17871.7B","volume":"64","author":"M Onofrj","year":"2005","unstructured":"Onofrj M, Thomas A. Acute akinesia in Parkinson disease.Neurology 2005;64(7):1162\u20131169.","journal-title":"Neurology"}],"container-title":["Journal of Medical Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03178278.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03178278\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03178278","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,21]],"date-time":"2019-05-21T23:45:06Z","timestamp":1558482306000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03178278"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":8,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["BF03178278"],"URL":"https:\/\/doi.org\/10.1007\/bf03178278","relation":{},"ISSN":["1556-9039","1937-6995"],"issn-type":[{"value":"1556-9039","type":"print"},{"value":"1937-6995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,12]]}}}